ClinicalTrials.gg
CompletedNCT03266224Updated Aug 31, 2017

Digital Analysis of Ultrasonographic Images in Children With Wry Neck

An observational study in Torticollis Congenital and Wryneck, sponsored by Chang Gung Memorial Hospital. Completed. Open to participants aged Up to 12 Months. Per ClinicalTrials.gov, last updated 2017-08-31.

Sponsored by Chang Gung Memorial Hospital · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
29
Ages
Up to 12 Months
Sex
All
01

Study summary

Torticollis is a clinical sign or symptom that could be the result of a variety of underlying disorders. Among the etiologies, Congenital muscular torticollis (CMT) with impairment of the sternocleidomastoid (SCM) is the most frequent cause of torticollis in infants. CMT is a postural deformity detected at birth or shortly after birth, primarily resulting from unilateral shortening and fibrosis of the SCM. Infants with CMT display head tilt to one side, which is often combined with rotation of the head to the opposite side. In 2002, Chih-Chin Hsu et al. reported that CMT could be classified into four types. The majority of Type I and II fibrosis improved after conservative treatment. However, Type III and Type IV had more probability in need of surgical correction. However, this categorization lacks of objective and quantitative measurement and can be different by subjective judgement of different physicians. The purpose of this study is tried to perform digital analysis of ultrasonography images to establish an objective, quantitative method and to assess its relevance with clinical symptoms and prognosis.

This study will collect the children younger than one year-old who were impressed or suspected to have torticollis in physical medicine and rehabilitation clinic to assess the relationship between digitalization results of ultrasound image and clinical manifestations and prognosis. Digital image analysis of ultrasound which contains both sides of the SCM in transverse and longitudinal view for comparison of lesion side and sound side will be performed after the initial enrollment and every six months later. Evaluation of clinical manifestations includes measurement of side difference of angles in bilateral neck lateral flexion, rotation and habitual head position will performed using an arthrodial protractor by a trained member at the beginning of physical therapy and one month later, then every 2-3 months. All cases will be followed for 1 and a half years. We expect to find some typical characteristics of CMT through digital analysis of the SCM. These characteristics include the muscle thickness and intensity of echogenicity in the region of interest. The Pearson's correlation will be performed to analyze the relevance of quantitative side differences in ultrasonography and clinical manifestations including side differences of neck rotation, lateral flexion and habitual head position between lesion sides and sound sides.

Read the detailed description

Torticollis is a clinical sign or symptom that could be the result of a variety of underlying disorders. Among the etiologies, Congenital muscular torticollis (CMT) with impairment of the sternocleidomastoid (SCM) is the most frequent cause of torticollis in infants. CMT is a postural deformity detected at birth or shortly after birth, primarily resulting from unilateral shortening and fibrosis of the SCM muscle. Infants with CMT display head tilt to one side, which is often combined with rotation of the head to the opposite side. CMT is estimated to occur in one infant of every 300 live births. Plagiocephaly is reported as a coexisting impairment in 80% to 90.1% of children with CMT.

The pathophysiology and etiology of SCM impairment in CMT is still unknown. Prominent theories related to the cause of SCM impairment in CMT include intrauterine crowding, muscle trauma during a difficult delivery, soft tissue compression leading to compartment syndrome, and congenital abnormalities of soft tissue differentiation within the SCM muscle.

Children with CMT can be assigned to one of three clinical subgroups: 1) children with a palpable swelling or pseudotumor of the sternocleidomastoid, 2) children with SCM tightness but no tumor, and 3) children with all the features of muscular torticollis without muscle tightness or tumor.

In 2002, Chih-Chin Hsu et al. reported that CMT could be classified into four types. Type I denoted a heteroechoic mass in the affected muscles; Type II represented diffuse echogenic dots and lines against the hypoechoic background with no detectable mass. The alignment of perimysium appeared irregular instead of parallel on longitudinal sonograms; Type III indicated diffuse hyperechoic echogenicity along the entire muscle and almost no hypoechoic background could be seen; and Type IV had a hyperechoic band in the involved muscles. The study also evaluated the histology of each type of fibrosis. Type I and II fibrosis revealed hyperplastic fibrous tissue mingled with muscle fiber. Mature fibroblasts with complete absence of normal muscle tissue could be found in Type III fibrosis and the fibrotic bands in Type IV fibrosis. The majority of Type I and II fibrosis improved after conservative treatment. However, Type III and Type IV had more probability in need of surgical correction. However, this categorization lacks of objective and quantitative measurement and can be different by subjective judgement of different physicians. The purpose of this study is tried to perform digital analysis of ultrasonography images to establish an objective, quantitative method and to assess its relevance with clinical symptoms and prognosis.

General Design:

This study is planned to quantify ultrasonography image of wry neck patients by digital analysis.

Subjects:

This study will collect the children younger than 1 y/o who were impressed or suspected to have torticollis in physical medicine and rehabilitation clinic. The case number is estimated around 60 in a 3-year-period enrollment. . Exclusion criteria include torticollis by other known causes like strabismus, trauma, neurogenic problems, congenital malformation or bony deformity (e.g. hemivertebrae of cervical spine). Informed consent will be given to the parents before enrollment.

Investigation Steps:

  1. Ultrasonography examination and digital analysis:

    Ultrasonography which contains both sides of the sternocleidomastoid muscle in transverse and longitudinal view for comparison of lesion side and sound side will be performed by expert physicians using a 14-megahertz linear-array transducer after the initial enrollment and every six months later. Digital analysis of the images will be carried by a member expert in computer science.

  2. Evaluation of clinical manifestations:

    Evaluation of clinical manifestations includes measurement of side difference of angles in bilateral neck lateral flexion, rotation and habitual head position will performed using an arthrodial protractor by a trained member at the beginning of physical therapy and one month later, then every 2-3 months. Each measurement will be repeated 3 times to get the mean value. All cases will be followed for 1 and a half years, however, if the symptoms got completely recovery (the neck range of motion and position completely equal to sound side) or any complications resulting from the evaluation, the evaluation will be stopped.

  3. Evaluation of influence of rehabilitation effect:

The parents will be inquired by a questionnaire one month later and then every 2-3 months to realize the treatment effect of the wry neck. The duration and frequency of massage and stretch programs by the therapist or the family or the other methods to treat the problem like wearing a neck collar, proper positioning... etc will be included in the semi-quantitative questionnaire.

Data Analysis:

Some representative image features will be expected to be computed from the SCM ultrasonic images. These features include area, both max and min Feret's diameters, and brightness of echogenicity in the region of interest. The ultrasonic image of the affected side would be compared with that of the sound side from their corresponding texture features. The Pearson's correlation will be performed to analyze the relevance of quantitative side differences of texture features in ultrasonography and clinical manifestations including side differences of neck rotation, lateral flexion and habitual head position between lesion sides and sound sides. Linear regression will be also used to adjust the influence of the treatment effect.

02

Conditions studied

  • Torticollis Congenital
  • Wryneck

Keywords

  • congenital muscular torticollis
  • wryneck
  • sternocleidomastoid
  • ultrasonography
  • digital analysis
03

In context

Congenital torticollis

21 studies on the registry are indexed under Congenital torticollis; 4 are open to participants now.

Browse Congenital torticollis studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,096 studies on the registry; 239 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

primary care clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. infants with congenital muscular torticollis and
  2. age \<12 months at diagnosis

Exclusion criteria

Exclusion Criteria:

(1) wryneck caused by other known problems, including strabismus, trauma, neurogenic problems, congenital malformation, or bony deformity (e.g., hemivertebrae of the cervical spine)

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
29 participants (actual)
Patient registry
No

Groups and cohorts

  • Wryneck

    those with a condition

06

What researchers measure

Primary outcomes

  1. cervical passive range of motion

    Measurement with an arthrodial protractor by a trained physiotherapist at the beginning of physical therapy and one month later, then every 2-3 months. Each measurement will be repeated 3 times to get the mean value.. All cases will be followed for 1 and a half years, however, if the symptoms got completely recovery (the neck range of motion and position completely equal to sound side) or any complications resulting from the evaluation, the evaluation will be stopped.

    Time frame: From the date of beginning of physical therapy until the date of wryneck condition resolved or date of any complications resulting from the evaluation, whichever came first, assessed up to 18 months.

Secondary outcomes

  1. Area in cm^2

    Ultrasonography which contains both sides of the sternocleidomastoid muscle in transverse and longitudinal view for comparison of lesion side and sound side will be performed by expert physicians using a 14-megahertz linear-array transducer after the initial enrollment and every six months later. Digital analysis of the images will be carried by a member expert in computer science. The area was measured in pixels on the original image. Thus, dividing by the pixels of one square centimeter on each sonogram, the unit of the area was converted to square centimeter.

    Time frame: From the date of initial enrollment until the date of wryneck condition resolved or date of any complications resulting from the evaluation, whichever came first, assessed up to 18 months.

  2. Brightness of echogenicity in %

    Ultrasonography which contains both sides of the sternocleidomastoid muscle in transverse and longitudinal view for comparison of lesion side and sound side will be performed by expert physicians using a 14-megahertz linear-array transducer after the initial enrollment and every six months later. Digital analysis of the images will be carried by a member expert in computer science. The sonograms were grayscale images, and the mean gray value was measured from 0 to 255 in the image analysis software where zero was designated black and 255 was designated white. Therefore, the mean gray value was divided by 255 and then converted to a percentage. In this study, zero percent was designated black, and 100% was designated white and indicated the brightness of the echogenicity on the sonogram.

    Time frame: From the date of initial enrollment until the date of wryneck condition resolved or date of any complications resulting from the evaluation, whichever came first, assessed up to 18 months.

  3. max Feret's diameter in cm

    Ultrasonography which contains both sides of the sternocleidomastoid muscle in transverse and longitudinal view for comparison of lesion side and sound side will be performed by expert physicians using a 14-megahertz linear-array transducer after the initial enrollment and every six months later. Digital analysis of the images will be carried by a member expert in computer science. The max Feret's diameter was measured in pixels on the original image. Thus, dividing by the pixels of one centimeter on each sonogram, the unit of the max Feret's diameter was converted to centimeter.

    Time frame: From the date of initial enrollment until the date of wryneck condition resolved or date of any complications resulting from the evaluation, whichever came first, assessed up to 18 months.

  4. min Feret's diameter in cm

    Ultrasonography which contains both sides of the sternocleidomastoid muscle in transverse and longitudinal view for comparison of lesion side and sound side will be performed by expert physicians using a 14-megahertz linear-array transducer after the initial enrollment and every six months later. Digital analysis of the images will be carried by a member expert in computer science. The min Feret's diameter was measured in pixels on the original image. Thus, dividing by the pixels of one centimeter on each sonogram, the unit of the min Feret's diameter was converted to centimeter.

    Time frame: From the date of initial enrollment until the date of wryneck condition resolved or date of any complications resulting from the evaluation, whichever came first, assessed up to 18 months.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Cheng JC, Tang SP, Chen TM, Wong MW, Wong EM. The clinical presentation and outcome of treatment of congenital muscular torticollis in infants--a study of 1,086 cases. J Pediatr Surg. 2000 Jul;35(7):1091-6. doi: 10.1053/jpsu.2000.7833. PubMed 10917303 ↗
  • Canale ST, Griffin DW, Hubbard CN. Congenital muscular torticollis. A long-term follow-up. J Bone Joint Surg Am. 1982 Jul;64(6):810-6. PubMed 7085709 ↗
  • Hollier L, Kim J, Grayson BH, McCarthy JG. Congenital muscular torticollis and the associated craniofacial changes. Plast Reconstr Surg. 2000 Mar;105(3):827-35. doi: 10.1097/00006534-200003000-00001. No abstract available. PubMed 10724239 ↗
  • Cheng JC, Wong MW, Tang SP, Chen TM, Shum SL, Wong EM. Clinical determinants of the outcome of manual stretching in the treatment of congenital muscular torticollis in infants. A prospective study of eight hundred and twenty-one cases. J Bone Joint Surg Am. 2001 May;83(5):679-87. doi: 10.2106/00004623-200105000-00006. PubMed 11379737 ↗
  • Clarren SK, Smith DW, Hanson JW. Helmet treatment for plagiocephaly and congenital muscular torticollis. J Pediatr. 1979 Jan;94(1):43-6. doi: 10.1016/s0022-3476(79)80347-9. PubMed 758420 ↗
  • Cheng JC, Au AW. Infantile torticollis: a review of 624 cases. J Pediatr Orthop. 1994 Nov-Dec;14(6):802-8. PubMed 7814599 ↗
  • Dunn PM. Congenital postural deformities. Br Med Bull. 1976 Jan;32(1):71-6. doi: 10.1093/oxfordjournals.bmb.a071327. No abstract available. PubMed 130955 ↗
  • Ling CM, Low YS. Sternomastoid tumor and muscular torticollis. Clin Orthop Relat Res. 1972 Jul-Aug;86:144-50. doi: 10.1097/00003086-197207000-00020. No abstract available. PubMed 5065412 ↗
  • Davids JR, Wenger DR, Mubarak SJ. Congenital muscular torticollis: sequela of intrauterine or perinatal compartment syndrome. J Pediatr Orthop. 1993 Mar-Apr;13(2):141-7. PubMed 8459000 ↗
  • Tang S, Liu Z, Quan X, Qin J, Zhang D. Sternocleidomastoid pseudotumor of infants and congenital muscular torticollis: fine-structure research. J Pediatr Orthop. 1998 Mar-Apr;18(2):214-8. PubMed 9531404 ↗
  • Tang SF, Hsu KH, Wong AM, Hsu CC, Chang CH. Longitudinal followup study of ultrasonography in congenital muscular torticollis. Clin Orthop Relat Res. 2002 Oct;(403):179-85. doi: 10.1097/00003086-200210000-00026. PubMed 12360024 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2013 to primary completion in Aug 2015, 27 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2017
First posted
Aug 30, 2017
StartActual
Apr 30, 2013
Primary completionActual
Aug 15, 2015
CompletionActual
Aug 15, 2015
Last update
Aug 31, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03266224
Responsible party
Chu-Hsu Lin (Principal Investigator, Chang Gung Memorial Hospital) — Principal investigator
First posted
Aug 30, 2017
Start date
Apr 30, 2013
Primary completion
Aug 15, 2015
Completion
Aug 15, 2015
Last update
Aug 31, 2017

Study contacts

Chu-Hsu Lin, MD
principal investigator · Chang Gung Memorial Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion